Characteristics of 114 nasal stage IE/IIE extranodal NK/T-cell lymphoma patients
Characteristic . | No. of patients (%) . |
|---|---|
| Age, n = 114 | |
| 60 y old or younger | 94 (82) |
| Older than 60 y | 20 (18) |
| Sex, n = 114 | |
| Male | 72 (63) |
| Female | 42 (37) |
| Primary sites of tumor, n = 114 | |
| Nasal cavity | 73 (64) |
| Nasopharynx | 21 (18) |
| Oral cavity/oropharynx | 15 (13) |
| Hypopharynx | 5 (4) |
| Systemic symptoms, n = 113 | |
| No | 78 (69) |
| Yes | 35 (31) |
| Performance status, n = 114 | |
| 0-1 | 108 (95) |
| 2 or higher | 6 (5) |
| Ann Arbor stage, n = 114 | |
| IE | 83 (73) |
| IIE | 31 (27) |
| LDH level, n = 109 | |
| Normal | 75 (69) |
| Elevated | 34 (31) |
| No. of extranodal sites, n = 114 | |
| 0-1 | 105 (92) |
| 2 or more | 9 (8) |
| International Prognostic Index rating, n = 112 | |
| 0-1 | 100 (89) |
| 2 or higher | 12 (11) |
| Immunophenotyping, n = 106 | |
| CD56+CD3ϵ+CD20- | 92 (87) |
| CD56-CD3ϵ+CD20- | 12 (11) |
| CD56+CD3ϵ-CD20- | 2 (2) |
Characteristic . | No. of patients (%) . |
|---|---|
| Age, n = 114 | |
| 60 y old or younger | 94 (82) |
| Older than 60 y | 20 (18) |
| Sex, n = 114 | |
| Male | 72 (63) |
| Female | 42 (37) |
| Primary sites of tumor, n = 114 | |
| Nasal cavity | 73 (64) |
| Nasopharynx | 21 (18) |
| Oral cavity/oropharynx | 15 (13) |
| Hypopharynx | 5 (4) |
| Systemic symptoms, n = 113 | |
| No | 78 (69) |
| Yes | 35 (31) |
| Performance status, n = 114 | |
| 0-1 | 108 (95) |
| 2 or higher | 6 (5) |
| Ann Arbor stage, n = 114 | |
| IE | 83 (73) |
| IIE | 31 (27) |
| LDH level, n = 109 | |
| Normal | 75 (69) |
| Elevated | 34 (31) |
| No. of extranodal sites, n = 114 | |
| 0-1 | 105 (92) |
| 2 or more | 9 (8) |
| International Prognostic Index rating, n = 112 | |
| 0-1 | 100 (89) |
| 2 or higher | 12 (11) |
| Immunophenotyping, n = 106 | |
| CD56+CD3ϵ+CD20- | 92 (87) |
| CD56-CD3ϵ+CD20- | 12 (11) |
| CD56+CD3ϵ-CD20- | 2 (2) |